Cerevance Patents – Insights & Stats (Updated 2023)

Cerevance has a total of 24 patents globally. Of these 24 patents, more than 66% patents are active. United Kingdom is where Cerevance has filed the maximum number of patents. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Cerevance.

Cerevance was founded in 2016. Cerevance is a company that develops innovative treatments with the goal of creating new medications for severe neurological conditions.

Do read about some of the most popular patents of Cerevance which have been covered by us in this article and also you can find Cerevance patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cerevance patent portfolio.

How many patents does Cerevance have?

Cerevance has a total of 24 patents globally. These patents belong to 14 unique patent families. Out of 24 patents, 16 patents are active.

How Many Patents did Cerevance File Every Year?

Cerevance Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCerevance Applications FiledCerevance Patents Granted
20236
202211
20214
20202
20191

How many Cerevance patents are Alive/Dead?

Worldwide Patents

Cerevance Patent Portfolio

How Many Patents did Cerevance File in Different Countries?

Cerevance Worldwide Patent Filing

Countries in which Cerevance Filed Patents

CountryPatent
United Kingdom11
Brazil1
New Zealand1
Mexico1
Europe1
Canada1
Singapore1
South Africa1
Australia1
Israel1

Where are Research Centers of Cerevance Patents Located?

R&D Centres of Cerevance

List of Cerevance patents

Cerevance PatentsTitle
EP4211118A1Substituted Pyrimidine Derivatives As Nicotinic Acetylcholinesterase Receptor Alpha 6 Modulator
WO2023209368A1Nitrogen Comprising Heterocyclic Derivatives For The Treatment Of Disorders Associated With Gpr55 Receptor
WO2023084206A1N-(4-Aminocyclohexyl)Pyrimidine-4-Carboxamide Derivatives As Cd38 Inhibitors
AU2022215916A1Novel Compounds
CA3207461A1Novel Compounds
IL303838ANovel Compounds
SG11202304919TANovel Compounds
BR112023015913A2New Compounds
GB202307427D0Novel Compounds
GB202307426D0Novel Compounds
GB2610812ANovel Compounds
GB202216323D0Novel Compounds
GB202216324D0Novel Compounds
MX2023009285ANovel Compounds
ZA202308463ANovel Compounds
NZ802792ANovel Compounds
WO2022167819A1Novel Compounds
WO2022053823A1Substituted Pyrimidine Derivatives As Nicotinic Acetylcholinesterase Receptor Alpha 6 Modulator
GB202207721D0Novel Compounds
GB202206054D0Novel Compounds
GB202101734D0Novel Compounds
GB202014341D0Novel Compounds
GB202014342D0Novel Compounds
GB201907535D0Novel Compounds

What are Cerevance key innovation segments?

What Technologies are Covered by Cerevance?

The chart below distributes patents filed by Cerevance in different countries on the basis of the technology protected in patents. It also represents the markets where Cerevance thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cerevance search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cerevance?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.